HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French Authority Asks For More Data On Turmeric Supplements After Hepatitis Cases Reported

Executive Summary

Following reports of side-effects linked to turmeric supplement use in France and Italy, the former's Agency for Food, Environmental and Occupational Health & Safety (ANSES) is asking manufacturers selling turmeric supplements in the country to provide additional bioavailability data. ANSES is concerned that new formulations are pushing consumers over the recommended daily intake limit set by the European Food Safety Authority. 

You may also be interested in...



Japan’s Theravalues Clinical Trial Claims Curcumin Benefits For Common Cold

Japanese curcumin specialist Theravalues claims to have found via a randomized clinical trial that its Theracurmin and Theracurmin Super dietary supplements can help alleviate some symptoms of the common cold. “However, the level of evidence is weak,” they warn. “Additionally, because the study was based on the reporting of subjective cold-like symptoms, it is was unclear whether the symptoms were actual subjective symptoms caused by an upper respiratory tract infection.”

Italian Ministry Of Health Bans Turmeric Health Claims, Updates Product Labeling

Italy's Ministry of Health has ordered warnings be added to turmeric-based supplements and banned health claims following hepatitis cases relating their use. 

UK Turmeric Shot Marketer Served A Regulatory Lesson For Unauthorized Pain Relief Claims

Firm apologized and removed a Facebook post that promised to rid users of stubborn aches and pains after Advertising Standards Authority determined claims were unauthorized.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel